Trial design
CERVICAL CANCER
This study was a single-center, phase 2, randomized controlled trial registered under Chinese clinical trial number ChiCTR2000030160. Data was gathered from patients with FIGO (2018) stage IA1 (lymphovascular invasion), IA2, and IB1 cervical cancer at Zhongda Hospital of Southeast University in Nanjing, China, between March 2020 and July 2021. The institutional review board evaluated and approved relevant medical ethics issues (ethical approval number 2020ZDSYLL106-Y01). The study design flowchart is shown in Fig. Laparoscopic vaginal stump closure using the endocutter